Clinical expert opinion on the role of elosulfase alfa in non-ambulatory individuals with Morquio A syndrome
{{output}}
Background: Morquio A syndrome is associated with progressive loss of ambulatory capacity. The impact of elosulfase alfa enzyme replacement therapy (ERT), the approved treatment for Morquio A, remains understudied in non-ambulato... ...
